Russell Investments Group
DERM icon

Russell Investments Group’s Journey Medical DERM Stock Holding History

Russell Investments Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.1K Buy
1,301
+185
+17% +$1.44K ﹤0.01% 3863
2025
Q4 		$8.6K Sell
1,116
-7,456
-87% -$58.5K ﹤0.01% 3834
2025
Q3 		$61K Buy
+8,572
New +$62.2K ﹤0.01% 3199

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group's DERM Position: Q1 2026 in Review

Russell Investments Group increased its Journey Medical (DERM) stake by 17% in Q1 2026, buying an estimated $1.44K and bringing the position to 1,301 shares worth $6.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3863.

Russell Investments Group first reported a position in DERM in Q3 2025 and has held it in 3 quarters since. The position peaked at $61K in Q3 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Russell Investments Group held 1,301 shares of Journey Medical worth $6.1K as of Q1 2026.
  • Russell Investments Group bought 185 Journey Medical shares in Q1 2026, an estimated $1.44K.
  • Journey Medical made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3863 holding.
  • Russell Investments Group first reported a position in Journey Medical in Q3 2025 and has held it in 3 quarters since.
  • Russell Investments Group's Journey Medical position peaked at $61K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.